Disclosed herein are methods of treating overactive bladder in a patient, the method comprising identifying a patient in need thereof； and administering to the patient a composition comprising tolterodine, or a pharmaceutically acceptable salt thereof, and pilocarpine, or a pharmaceutically acceptable salt thereof, wherein after the administration Cmax for tolterodine is between 1.0-8.0 ng/mL.
